457
Views
80
CrossRef citations to date
0
Altmetric
Review

Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review

, , , &
Pages 305-322 | Published online: 23 Feb 2017

References

  • Breast Cancer Statistics [webpage on the Internet]Cancer Research UK Web Site2016 Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancerAccessed October 10, 2016
  • GrayRGReaDHandleyKATTom: long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancerJ Clin Oncol201318315
  • Early Breast Cancer Trialists’ Collaborative GroupTamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative GroupLancet19983519114145114679605801
  • BarronTICahirCSharpLBennettKA nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I–III breast cancerBr J Cancer201310961513152124002590
  • HershmanDLShaoTKushiLHEarly discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerBreast Cancer Res Treat2011126252953720803066
  • MakubateBDonnanPTDewarJAThompsonAMMcCowanCCohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortalityBr J Cancer201310871515152423519057
  • HuiartLBouhnikA-DReyDComplementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancerPLoS One2013812e8167724367488
  • HershmanDLKushiLHShaoTEarly discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patientsJ Clin Oncol201028274120412820585090
  • PartridgeAHWangPSWinerEPAvornJNonadherence to adjuvant tamoxifen therapy in women with primary breast cancerJ Clin Oncol200321460260612586795
  • CluzeCReyDHuiartLAdjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over timeAnn Oncol201223488289021788360
  • OwusuCBuistDSFieldTSPredictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancerJ Clin Oncol200826454955518071188
  • HorneRWeinmanJSelf-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medicationPsychol Health20021711732
  • ChilcotJWellstedDFarringtonKIllness representations are associated with fluid nonadherence among hemodialysis patientsJ Psychosom Res201068220321220105704
  • GouldingLFurzeGBirksYRandomized controlled trials of interventions to change maladaptive illness beliefs in people with coronary heart disease: systematic reviewJ Adv Nurs201066594696120423355
  • PetrieKJPerryKBroadbentEWeinmanJA text message programme designed to modify patients’ illness and treatment beliefs improves self-reported adherence to asthma preventer medicationBr J Health Psychol2012171748422107110
  • MurphyCCBartholomewLKCarpentierMYBluethmannSMVernonSWAdherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic reviewBreast Cancer Res Treat2012134245947822689091
  • CahirCGuinanEDombrowskiSUSharpLBennettKIdentifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I–III breast cancer: a systematic review and meta-analysisPatient Educ Couns Epub2015530
  • Van LiewJRChristensenAJde MoorJSPsychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence researchJ Cancer Surviv20148352153124986227
  • LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationBMJ2009339b270019622552
  • McCowanCWangSThompsonAMMakubateBPetrieDJThe value of high adherence to tamoxifen in women with breast cancer: a community-based cohort studyBr J Cancer201310951172118023949153
  • PasmaAvan’t SpijkerAHazesJMWBusschbachJJVLuimeJJFactors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic reviewSemin Arthritis Rheum2013431182823352247
  • SandersonSTattIDHigginsJPTools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliographyInt J Epidemiol200736366667617470488
  • BritoCPortelaMCde VasconcellosMTLAdherence to hormone therapy among women with breast cancerBMC Cancer201414139724893670
  • BritoCPortelaMCLeite de VasconcellosMTFactors associated to persistence with hormonal therapy in women with breast cancerRev Saude Publica201448228429524897050
  • LashTLFoxMPWestrupJLFinkAKSillimanRAAdherence to tamoxifen over the five-year courseBreast Cancer Res Treat200699221522016541307
  • FinkAKGurwitzJRakowskiWGuadagnoliESillimanRAPatient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancerJ Clin Oncol200422163309331515310774
  • KimmickGEdmondSNBosworthHBMedication taking behaviors among breast cancer patients on adjuvant endocrine therapyBreast201524563063626189978
  • TinariNFanizzaCRomeroMIdentification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian surveyClin Breast Cancer2015152e131e13725454738
  • WoutersHStiggelboutAMBouvyMLEndocrine therapy for breast cancer: assessing an array of women’s treatment experiences and perceptions, their perceived self-efficacy and nonadherenceClin Breast Cancer2014146460467.e224981234
  • HershmanDLTsuiJMeyerJThe change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancerJ Natl Cancer Inst201410611dju31925349080
  • HershmanDLTsuiJWrightJDCoromilasEJTsaiWYNeugutAIHousehold net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancerJ Clin Oncol20153391053105925691670
  • NeugutAISubarMWildeETAssociation between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancerJ Clin Oncol201129182534254221606426
  • LeeHSLeeJYAhYMLow adherence to upfront and extended adjuvant letrozole therapy among early breast cancer patients in a clinical practice settingOncology2014865–634034924925302
  • SedjoRLDevineSPredictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancerBreast Cancer Res Treat2011125119120020495864
  • StantonALPetrieKJPartridgeAHContributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registryBreast Cancer Res Treat2014145252553424781972
  • TrabulsiNReidelKEWinsladeNEAdherence to anti-estrogen therapy in seniors with breast cancer: how well are we doing?Breast J201420663263825251847
  • WigertzAAhlgrenJHolmqvistMAdherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based studyBreast Cancer Res Treat2012133136737322286315
  • FontREspinasJAGil-GilMPrescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, SpainBr J Cancer201210781249125622955858
  • HsiehK-PChenL-CCheungK-LYangY-HRisks of nonadherence to hormone therapy in Asian women with breast cancerKaohsiung J Med Sci201531632833426043413
  • BenderCMGentryALBrufskyAMInfluence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancerOncol Nurs Forum201441327428524769592
  • WickershamKESereikaSMBenderCMPretreatment predictors of short-term nonadherence to oral hormonal therapy for women with breast cancerNurs Res201362424325123817282
  • SchoverLRBaumGPFusonLABrewsterAMelhem-BertrandtASexual problems during the first 2 years of adjuvant treatment with aromatase inhibitorsJ Sex Med201411123102311125141792
  • HadjiPZillerVKyvernitakisJPersistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysisBreast Cancer Res Treat2013138118519123334803
  • KostevKWaehlertLJockwigAJockwigBHadjiPPhysicians’ influence on breast cancer patient complianceGer Med Sci201412 Doc03
  • KostevKMayUHogDAdherence in tamoxifen therapy after conversion to a rebate pharmaceutical in breast cancer patients in GermanyInt J Clin Pharmacol Ther2013511296997524120719
  • CorterALTreatment Side Effects and Nonadherence among Women Taking Adjuvant Endocrine Therapy for Breast Cancer: The Role of Psychological Factors [PhD thesis]AucklandThe University of Auckland2013
  • DemissieSSillimanRALashTLAdjuvant tamoxifen: predictors of use, side effects, and discontinuation in older womenJ Clin Oncol200119232232811208822
  • KahnKLSchneiderECMalinJLAdamsJLEpsteinAMPatient centered experiences in breast cancer – predicting long-term adherence to tamoxifen useMed Care200745543143917446829
  • KempAPreenDBSaundersCEarly discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?Springerplus2014328224936397
  • LiuYMalinJLDiamantALThindAMalyRCAdherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communicationBreast Cancer Res Treat2013137382983623263740
  • Aiello BowlesEJBoudreauDMChubakJPatient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancerJ Oncol Pract201286e149e15723598850
  • RileyGFWarrenJLHarlanLCBlackwellSAEndocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part DMedicare Medicaid Res Rev201114
  • GuthUMyrickMEKilicNEppenberger-CastoriSSchmidSMCompliance and persistence of endocrine adjuvant breast cancer therapyBreast Cancer Res Treat2012131249149921976056
  • BarronTIConnollyRBennettKFeelyJKennedyMJEarly discontinuation of tamoxifen: a lesson for oncologistsCancer2007109583283917243168
  • FrieseCRPiniTMLiYAdjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancerBreast Cancer Res Treat2013138393193923542957
  • KrotnevaSPRamjaunAReidelKEUse of hormonal therapy in senior breast cancer patients treated with or without radiotherapyCurr Oncol2014211e105e11524523607
  • NekhlyudovLLiLRoss-DegnanDWagnerAKFive-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancerBreast Cancer Res Treat2011130268168921842245
  • WuJStafkey-MaileyDBennettCLLong-term adherence to hormone therapy in medicaid-enrolled women with breast cancerHealth Outcomes Res Med201234e195e203
  • SeneviratneSCampbellIScottNAdherence to adjuvant endocrine therapy: is it a factor for ethnic differences in breast cancer outcomes in New Zealand?Breast2015241626725486877
  • SchmidtNKostevKJockwigAKyvernitakisIAlbertUSHadjiPTreatment persistence evaluation of tamoxifen and aromatase inhibitors in breast cancer patients in early and late stage diseaseInt J Clin Pharmacol Ther2014521193393925207549
  • BhattaSSHouNMotonZNFactors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancerSpringerplus2013235623961419
  • HeWFangFVarnumCErikssonMHallPCzeneKPredictors of discontinuation of adjuvant hormone therapy in patients with breast cancerJ Clin Oncol201533202262226926033800
  • van Herk-SukelMPvan de Poll-FranseLVVoogdACNieuwenhuijzenGACoeberghJWHeringsRMHalf of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysisBreast Cancer Res Treat2010122384385120058066
  • SheppardVBFaulLALutaGFrailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901J Clin Oncol201432222318232724934786
  • LlarenaNCEstevezSLTuckerSLJerussJSImpact of fertility concerns on tamoxifen initiation and persistenceJ Natl Cancer Inst201510710djv20226307641
  • GrunfeldEAHunterMSSikkaPMittalSAdherence beliefs among breast cancer patients taking tamoxifenPatient Educ Couns20055919710216198223
  • Jacob ArriolaKRMasonTABannonKAModifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patientsPatient Educ Couns20149519810324492157
  • WalkerHERosenbergSMStantonALPetrieKJPartridgeAHPerceptions, attributions, and emotions toward endocrine therapy in young women with breast cancerJ Adolesc Young Adult Oncol201651162326812461
  • KarmakarMPredicting Adherence to Aromatase Inhibitor Therapy in Patients with Breast Cancer Using Protection Motivation Theory [PhD thesis]ToledoThe University of Toledo2013
  • HuiartLBouhnikADReyDEarly discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?Eur J Cancer201248131939194622464016
  • GotayCDunnJAdherence to long-term adjuvant hormonal therapy for breast cancerExpert Rev Pharmacoecon Outcomes Res2011116709715
  • WheelerSBRobertsMCBloomDOncology providers’ perspectives on endocrine therapy prescribing and managementPatient Prefer Adherence2016102007201927757021
  • HoganBELindenWNajarianBSocial support interventions: do they work?Clin Psychol Rev200222338344217201192
  • VerbruggheMVerhaegheSLauwaertKBeeckmanDVan HeckeADeterminants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic reviewCancer Treat Rev201339661062123428230
  • BarrRSomersSCSpeizerFECamargoCAJrNational Asthma Education and Prevention Program (NAEPP)Patient factors and medication guideline adherence among older women with asthmaArch Inten Med20021621517611768
  • CompasBEStollMFThomsenAHOppedisanoGEpping-JordanJEKragDNAdjustment to breast cancer: age-related differences in coping and emotional distressBreast Cancer Res Treat199954319520310445418
  • PartridgeAHAvornJWangPSWinerEPAdherence to therapy with oral antineoplastic agentsJ Natl Cancer Inst200294965266111983753
  • KnodelJKespichayawattanaJSaengtienchaiCWiwatwanichSThe role of parents and family members in ART treatment adherence: evidence from ThailandRes Aging2010321193920221313
  • BarreraMGlasgowREMcKayHGBolesSMFeilEGDo internet-based support interventions change perceptions of social support?: an experimental trial of approaches for supporting diabetes self-managementAm J Community Psychol200230563765412188054
  • CzechuraTWinchesterDJPesceCBarreraEWinchesterDPYaoKImpact of bilateral versus unilateral mastectomy on short term outcome and adjuvant therapyAnn Surg Oncol20131S49
  • AshfordSEdmundsJFrenchDPWhat is the best way to change self-efficacy to promote lifestyle and recreational physical activity? A systematic review with meta-analysisBr J Health Psychol201015226528819586583
  • PrestwichAKellarIParkerRHow can self-efficacy be increased? Meta-analysis of dietary interventionsHealth Psychol Rev20148327028525053214
  • HorneRWeinmanJPatients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illnessJ Psychosom Res199947655556710661603
  • ClatworthyJBowskillRParhamRRankTScottJHorneRUnderstanding medication non-adherence in bipolar disorders using a Necessity-Concerns FrameworkJ Affect Disord20091161–2515519101038
  • O’CarrollREChambersJADennisMSudlowCJohnstonMImproving adherence to medication in stroke survivors: a pilot randomised controlled trialAnn Behav Med201346335836823670112
  • ByerBMyersLBPsychological correlates of adherence to medication in asthmaPsychol Health Med200054389393
  • WetzelsGENelemansPJSchoutenJSvan WijkBLPrinsMHAll that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions – an observational studyBMC Health Serv Res20066816472388
  • RuddyKMayerEPartridgeAPatient adherence and persistence with oral anticancer treatmentCA Cancer J Clin2009591566619147869
  • OberguggenbergerASSztankayMBeerBAdherence evaluation of endocrine treatment in breast cancer: methodological aspectsBMC Cancer20121247423066928
  • CheungWYLaiEC-CRuanJYChangJTSetoguchiSComparative adherence to oral hormonal agents in older women with breast cancerBreast Cancer Res Treat2015152241942726070268
  • DanilakMChambersCRAdherence to adjuvant endocrine therapy in women with breast cancerJ Oncol Pharm Pract201319210511022895656
  • KimmickGAndersonRCamachoFBhosleMHwangWBalkrishnanRAdjuvant hormonal therapy use among insured, low-income women with breast cancerJ Clin Oncol200927213445345119451445
  • KubaSIshidaMShigechiTPersistence and discontinuation of adjuvant endocrine therapy in Japanese women with breast cancerBreast Cancer201623112813324934610
  • LivaudaisJCLaCroixAChlebowskiRTRacial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women’s health initiativeCancer Epidemiol Biomarkers Prev20122236537323275187
  • SimonRLatreilleJMatteCDesjardinsPBergeronEAdherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-upCan J Surg2014571263224461223
  • ZillerVKalderMAlbertUSAdherence to adjuvant endocrine therapy in postmenopausal women with breast cancerAnn Oncol200920343143619150950
  • ZeeneldinAAGaberAATahaFMDoes fasting during Ramadan trigger non-adherence to oral hormonal therapy in breast cancer patients?J Egypt Natl Canc Inst201224313313722929919